Lab
Shiel Holdings LLC
Shiel Holdings LLC was paid $394K by Medicaid between Jan 2018 and Dec 2018, across 125 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 12% of everything it billed.
33Billing provider infoSHIEL HOLDINGS LLC
BROOKLYN, NY 11205
BROOKLYN, NY 11205
33aNPI1588093165assigned 11/05/2013
33bProvider typeClinical Medical Laboratory
28Total paid$394K
24GClaims39,852
24DCodes billed125
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#64 of 116
Median peer was paid$618K
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,852 | $394K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12% | 1,446 | 763 | $47K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.2% | 1,470 | 1,453 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.2% | 1,455 | 1,439 | $28K |
| 80050 | General health panel | 6.1% | 1,135 | 1,134 | $24K |
| 86480 | 4.8% | 545 | 543 | $19K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.4% | 1,009 | 1,007 | $13K |
| 84207 | 3.3% | 833 | 831 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.3% | 825 | 806 | $13K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.7% | 2,391 | 2,326 | $11K |
| 80053 | Comprehensive metabolic panel | 2.2% | 1,674 | 1,423 | $9K |
| 82607 | 1.9% | 960 | 840 | $8K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.9% | 381 | 376 | $7K |
113 more codes
| 80061 | Lipid panel | 1.8% | 1,024 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 1,697 | $7K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1.7% | 465 | $7K |
| 82746 | 1.6% | 827 | $6K | |
| 86780 | 1.5% | 823 | $6K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.5% | 300 | $6K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1.4% | 13 | $6K |
| 82728 | 1.2% | 758 | $5K | |
| 87081 | 1.1% | 1,212 | $4K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.1% | 79 | $4K |
| 87340 | 1.0% | 708 | $4K | |
| 84144 | <1% | 330 | $4K | |
| 80348 | <1% | 67 | $4K | |
| 86803 | <1% | 479 | $4K | |
| 81001 | <1% | 2,105 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 709 | $4K |
| 86747 | <1% | 334 | $4K | |
| 83655 | <1% | 502 | $3K | |
| 86762 | <1% | 413 | $3K | |
| 84439 | <1% | 672 | $3K | |
| 86787 | <1% | 422 | $3K | |
| 86765 | <1% | 408 | $3K | |
| 87088 | <1% | 651 | $3K | |
| 83550 | <1% | 702 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 73 | $3K |
| 87480 | <1% | 250 | $3K | |
| 87510 | <1% | 246 | $3K | |
| 87070 | <1% | 561 | $3K | |
| 86735 | <1% | 369 | $3K | |
| 82670 | <1% | 164 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 287 | $3K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 32 | $2K |
| 83540 | <1% | 738 | $2K | |
| 87660 | <1% | 212 | $2K | |
| 80373 | <1% | 186 | $2K | |
| 87186 | <1% | 399 | $2K | |
| 83002 | <1% | 176 | $2K | |
| 87077 | <1% | 378 | $2K | |
| 86696 | <1% | 136 | $2K | |
| 87799 | <1% | 29 | $2K | |
| 84480 | <1% | 200 | $2K | |
| 86850 | <1% | 334 | $1K | |
| 84153 | <1% | 151 | $1K | |
| 83001 | <1% | 138 | $1K | |
| 80081 | <1% | 30 | $1K | |
| 87481 | <1% | 42 | $1K | |
| 80349 | <1% | 104 | $1K | |
| 86695 | <1% | 139 | $1K | |
| 87147 | <1% | 343 | $982.08 | |
| 80346 | <1% | 86 | $933.10 | |
| 84403 | <1% | 66 | $926.55 | |
| 82950 | <1% | 336 | $891.91 | |
| 84146 | <1% | 73 | $834.14 | |
| 82378 | <1% | 121 | $798.89 | |
| 83021 | <1% | 74 | $751.06 | |
| 84702 | <1% | 85 | $724.47 | |
| 80354 | <1% | 62 | $672.70 | |
| 84550 | <1% | 262 | $650.90 | |
| 87512 | <1% | 31 | $625.94 | |
| 86900 | <1% | 363 | $609.98 | |
| 86901 | <1% | 360 | $604.75 | |
| 80321 | <1% | 13 | $494.00 | |
| 86140 | <1% | 165 | $459.00 | |
| 84481 | <1% | 44 | $397.98 | |
| 86777 | <1% | 42 | $350.01 | |
| 82248 | <1% | 124 | $339.72 | |
| 88312 | <1% | 12 | $330.16 | |
| 83516 | <1% | 17 | $317.25 | |
| 82550 | <1% | 91 | $306.46 | |
| 86038 | <1% | 45 | $299.91 | |
| 82043 | <1% | 99 | $295.02 | |
| 83735 | <1% | 85 | $291.89 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 395 | $289.06 |
| 83615 | <1% | 81 | $279.05 | |
| 86706 | <1% | 44 | $271.60 | |
| 85652 | <1% | 166 | $246.75 | |
| 86708 | <1% | 34 | $243.59 | |
| 83020 | <1% | 31 | $241.22 | |
| 86617 | <1% | 16 | $240.75 | |
| 86665 | <1% | 13 | $240.56 | |
| 83690 | <1% | 64 | $237.46 | |
| 82150 | <1% | 66 | $230.40 | |
| 80361 | <1% | 20 | $217.00 | |
| 86317 | <1% | 27 | $216.58 | |
| 86704 | <1% | 31 | $216.50 | |
| 86376 | <1% | 24 | $215.30 | |
| 86645 | <1% | 21 | $200.87 | |
| 80076 | <1% | 38 | $182.29 | |
| 86644 | <1% | 21 | $180.34 | |
| 86778 | <1% | 21 | $177.76 | |
| 86800 | <1% | 17 | $162.65 | |
| 86141 | <1% | 22 | $160.50 | |
| 82985 | <1% | 18 | $156.30 | |
| 84100 | <1% | 55 | $156.19 | |
| 81400 | <1% | 12 | $151.98 | |
| 80353 | <1% | 13 | $141.05 | |
| 83721 | <1% | 28 | $126.62 | |
| 83525 | <1% | 16 | $107.28 | |
| 82977 | <1% | 23 | $97.12 | |
| 85651 | <1% | 51 | $96.85 | |
| 85730 | <1% | 28 | $96.18 | |
| 85610 | <1% | 42 | $91.11 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15 | $77.78 |
| 85384 | <1% | 15 | $70.80 | |
| 82570 | <1% | 21 | $62.40 | |
| 86060 | <1% | 14 | $58.21 | |
| 85041 | <1% | 30 | $50.40 | |
| 82947 | <1% | 15 | $42.68 | |
| 85018 | <1% | 31 | $40.92 | |
| 85014 | <1% | 30 | $39.60 | |
| 84479 | <1% | 16 | $28.72 | |
| 84436 | <1% | 16 | $22.92 | |
| 81003 | <1% | 14 | $16.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAYDEN, PHILIP (VP OF FINANCE)